Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001027796-24-000033
Filing Date
2024-10-16
Accepted
2024-10-16 14:10:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 5330
  Complete submission text file 0001027796-24-000033.txt   7124
Mailing Address 320 PARK AVENUE, 8TH FLOOR NEW YORK NY 10022
Business Address 320 PARK AVENUE, 8TH FLOOR NEW YORK NY 10022 212-355-1600
PZENA INVESTMENT MANAGEMENT LLC (Filed by) CIK: 0001027796 (see all company filings)

EIN.: 000000000
Type: SCHEDULE 13G

Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Subject) CIK: 0001069899 (see all company filings)

EIN.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: SCHEDULE 13G | Act: 34 | File No.: 005-88114 | Film No.: 241374227
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)